"EFFECTIVE LUNG AGE" IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN THE SENSCIS TRIAL

Maher T, Bourdin A, Volkmann E, Vettori S, Distler J, Alves M, Stock C, Distler O (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 447-447

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2022-eular.746

Authors with CRIS profile

Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

University of Southern California (USC) US United States (USA) (US) University of Montpellier / Université Montpellier FR France (FR) University of California Los Angeles (UCLA) US United States (USA) (US) Ospedale Monaldi IT Italy (IT) Boehringer Ingelheim Pharma GmbH & Co. KG DE Germany (DE) University of Zurich / Universität Zürich (UZH) CH Switzerland (CH)

How to cite

APA:

Maher, T., Bourdin, A., Volkmann, E., Vettori, S., Distler, J., Alves, M.,... Distler, O. (2022). "EFFECTIVE LUNG AGE" IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN THE SENSCIS TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 447-447). LONDON: BMJ PUBLISHING GROUP.

MLA:

Maher, T., et al. ""EFFECTIVE LUNG AGE" IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN THE SENSCIS TRIAL." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2022. 447-447.

BibTeX: Download